Secondary Knee Osteoarthritis That Creeps In Years After Arthroscopic Partial Meniscectomy — Dr. Moriwaki Explains the Pathology of Reduced Contact Area and Shock Absorption, and What Stem Cell Conditioned Media Knee Injections Can (and Cannot) Do for the Intra-Articular Inflammatory Environment2026.08.02

“After I had arthroscopic partial meniscectomy for a torn meniscus, my knee pain went away — but a few years later a dull ache came back along the inner side of the knee.” Complaints like this are not rare. In orthopedic practice it has long been discussed that after post-meniscectomy surgery, secondary knee osteoarthritis can progress on a scale of several to more than ten years, in proportion to how much meniscus was removed. In this article, Dr. Shin Moriwaki of AVAN TOKYO Ginza explains what happens in the post-meniscectomy knee, and how injecting stem cell conditioned media into the knee joint may act on the intra-articular inflammatory environment — while being honest about its indications and limits.

Key Points of This Article

・Observational studies report that the post-meniscectomy knee has an elevated incidence of secondary knee osteoarthritis on a timescale of several to more than ten years, depending on how much meniscus remains

・The meniscus acts as the knee’s shock absorber; the more it is removed, the more directly load is transmitted to the cartilage

・Stem cell conditioned media injection into the knee joint is not a treatment that regrows lost meniscus tissue — it is a conservative option that aims to modulate the intra-articular inflammatory cytokine environment

・If dull inner-compartment pain, knee swelling, or catching on the stairs appears years after surgery, treat it as an early sign of secondary OA and get re-evaluated

・Lower-limb strength, weight control, and bracing form the base on which the knee injection has to be built to be meaningful

What Structurally Changes in the Post-Meniscectomy Knee

The meniscus is a C-shaped fibrocartilage wedged between the femur and tibia. It distributes load across the joint, cushions the cartilage from direct impact, and contributes to joint stability and lubrication. Arthroscopic partial meniscectomy removes the torn, unstable portion of the meniscus so the healthy remainder can continue its cushioning role. In many cases the mechanical catching and severe pain are relieved right after surgery.

However, whatever is removed reduces the contact area transmitting load, and pressure per unit area rises. Observational studies have repeatedly shown that a knee that has undergone partial resection tends to develop and progress osteoarthritis more often than the contralateral knee over several to more than ten years. The more meniscus removed — and especially when it is the lateral meniscus — the more pronounced this tendency. When a patient says “I fixed my knee, and now it hurts again,” secondary intra-articular inflammation and cartilage degeneration are frequently what is going on.

Don’t Miss the Early Signs of Secondary Knee Osteoarthritis

The early signs of secondary OA that emerge quietly years after post-meniscectomy include a nagging ache in the medial joint line, brief morning stiffness, a catching sensation on stairs, knee swelling with joint effusion, and a feeling of blockage when kneeling or squatting deeply. If dismissed with “I’m done thinking about the knee — surgery took care of it,” cartilage degeneration can advance until X-rays show a KL grade 2 or 3 picture. It is safer to treat the knee as a subject for periodic surveillance for many years post-op, and to seek re-evaluation as soon as symptoms return.

What Stem Cell Conditioned Media Knee Injections Can and Cannot Target

The critical line to draw is this: stem cell conditioned media injection into the knee does not regrow lost meniscus tissue. Meniscus that was removed will not come back with an injection. What can be targeted is the chronic intra-articular cytokine environment (skewed toward IL-1β and TNF-α) that lies behind secondary OA — the injection aims to nudge it in a calmer direction through anti-inflammatory and repair-related factors present in the media. Clinical evaluation looks at synovitis calming down, changes in synovial fluid character, and improvements in pain scores, range of motion, and daily activities such as stair use.

So it is honest to position this treatment as a “next step” candidate when a knee in the early-to-middle stage of secondary knee osteoarthritis after post-meniscectomy plateaus on weight management, exercise therapy, or hyaluronic acid injections. It is not indicated for end-stage KL 4 knees where the joint space has disappeared and bone rubs on bone; at that stage, total knee arthroplasty on a different axis becomes the realistic conversation. For general orthopedic information, please also refer to the Japanese Orthopaedic Association.

Designing the Knee Injection So It Is Not a “Stand-Alone” Treatment

Stem cell conditioned media knee injection is not an all-in-one treatment that protects the knee long-term on its own. To slow long-term cartilage degeneration, it only becomes meaningful on top of a base of conservative measures: maintaining lower-limb strength centered on the quadriceps and gluteus medius, weight control (a 1 kg increase in body weight translates to several kilograms of load on the knee), insoles and knee braces where appropriate, and distributing deep-flexion load in daily movements. Please also see our stem cell conditioned media joint injection page for more information. At our clinic we build the injection frequency and combined-therapy balance individually, based on years since surgery, current symptoms, imaging findings, and lifestyle.

Frequently Asked Questions

Q. It has been ten years since my partial meniscectomy. Is there still any point in considering a stem cell conditioned media knee injection now?

The premise is an assessment of your current knee symptoms (pain location, intensity, range of motion) and cartilage status on X-ray and, if needed, MRI. If you are in the early-to-middle stage of secondary knee OA, it is worth considering as an option combined with conservative therapy. Individual variation is real, and if end-stage severe cartilage degeneration or joint destruction is present, an orthopedic consultation about surgical options takes priority.

Q. Can a stem cell conditioned media knee injection bring back the meniscus that was removed?

No. This is not a treatment that reconstructs tissue itself; it aims to nudge the intra-articular inflammatory environment in a calmer direction. If you are told the injection will “restore lost meniscus tissue,” you should carefully verify the evidence behind that claim.

Q. Does the clinical course differ between knees where the medial meniscus was removed and those where the lateral meniscus was removed?

Observational studies have reported that cases with lateral meniscus resection tend to progress toward secondary knee osteoarthritis earlier and more clearly. The lateral meniscus carries a proportionally larger role in contact area and load sharing than the medial one. That said, weight, lower-limb alignment, and activity level all interact, so the course varies from person to person.

Q. How many stem cell conditioned media knee injections are needed, and at what interval?

A common design is several injections at intervals of a few weeks as an induction phase, then longer intervals in the maintenance phase depending on symptom course. There is no “guaranteed cure” number; continuation, adjustment, or discontinuation are judged from changes in pain scores, range of motion, and daily activities. Judging effect too early is also to be avoided.

──────────────

Supervising Physician: Shin Moriwaki, MD

Member, Japan Society of Aesthetic Surgery (JSAS) / Member, American Academy of Aesthetic Medicine

ECFMG Certificate (U.S. medical licensing qualification)

──────────────

📍AVAN TOKYO Ginza Regenerative Medicine

AVAN TOKYO Ginza Regenerative Medicine

English / 中文 / Tiếng Việt supported

Inquiries: DM / LINE / Website / Phone.